Screening for Anemia and Iron Deficiency in the Adult Portuguese Population

Author:

Robalo Nunes António12ORCID,Mairos João13,Brilhante Dialina14,Marques Filipa15,Belo Aurora16ORCID,Cortez José178,Fonseca Cândida158

Affiliation:

1. Anemia Working Group Portugal, Av. Columbano Bordalo Pinheiro 75, 1070-061 Lisbon, Portugal

2. Immunohemotherapy Service, Armed Forces Hospital (HFAR)–Lisbon, Azinhaga Dos Ulmeiros, Paço Do Lumiar, 1690-020 Lisbon, Portugal

3. Air Force Health Directorate–Lisbon, Azinhaga Dos Ulmeiros, Paço Do Lumiar, 1690-020 Lisbon, Portugal

4. Immunohemotherapy Service, Portuguese Institute of Oncology of Lisbon Francisco Gentil (IPO Lisboa), R. Prof. Lima Basto, 1099-023 Lisbon, Portugal

5. Medicine Service, São Francisco Xavier Hospital, Western Lisbon Hospital Center (CHLO), Estrada Do Forte Do Alto Do Duque, 1449-005 Lisbon, Portugal

6. Clinical Medicine Department, Armed Forces Hospital (HFAR)–Lisbon, Azinhaga Dos Ulmeiros, Paço Do Lumiar, 1690-020 Lisbon, Portugal

7. Clinical Pathology Department, Portuguese Institute of Oncology of Lisbon Francisco Gentil (IPO Lisboa), R. Prof. Lima Basto, 1099-023 Lisbon, Portugal

8. Nova Medical School, Faculty of Medical Sciences, Campo Mártires da Pátria 130, 1169-056 Lisbon, Portugal

Abstract

Anemia and iron deficiency (ID) can impair quality of life and socioeconomic development. We evaluated the prevalence of anemia and ID in the adult Portuguese population in real-life contexts by gender, age, and pregnancy status. We performed a cross-sectional screening in adult individuals in mainland Portugal from 2013 to 2017. Participants completed a survey about demographics and signs or symptoms compatible with anemia, and ID and hemoglobin and ferritin concentrations were determined by point-of-care tests. We estimated and compared prevalence ratios (PR) of anemia and ID using Poisson regression with robust variance and the Wald chi-square test. We collected data from 11,030 individuals (26% men, 64% nonpregnant women, and 10% pregnant women). We found anemia in 51.8% (95% CI 50.1–53.4%) of nonpregnant women in fertile age, 46.6% (95% CI 44.7–48.6%) of nonpregnant women >51 years, 38.2% (95% CI 35.4–41.1%) of pregnant women, and 33.3% (95% CI 31.6–35.1%) of men. The prevalence of ID was 72.9% (95% CI 71.4–74.4%) in nonpregnant women in fertile age, 50.5% (95% CI 48.5–52.4%) in nonpregnant women >51 years, 94.8% (95% CI 93.3–96.0%) in pregnant women, and 28.9% (95% CI 27.3–30.6%) in men. We found significant associations between the prevalence of anemia or ID and nonpregnant women (PR: 1.50, 95% CI 1.42–1.59 or PR: 2.21, 95% CI 2.09–2.35, respectively), manifestation of signs or symptoms (PR: 1.19, 95% CI 1.53–1.23 or PR: 1.22, 95% CI 1.18–1.26), pregnant women (PR: 0.74, 95% CI 0.68–0.80 or PR: 1.30, 95% CI 1.27–1.33), and nonpregnant women ≤51 years (PR: 1.11, 95% CI 1.06–1.17 or PR: 1.42, 95% CI 1.36–1.48). In conclusion, anemia and ID represent moderate to severe public health problems, particularly among women in fertile age and in 3rd trimester, of pregnancy emphasizing the need to raise the public and health professionals’ awareness of these problems and their prevention, diagnosis, and treatment.

Funder

Viphor Pharma

Publisher

Hindawi Limited

Subject

Cell Biology,Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3